[go: up one dir, main page]

AU2002235991A1 - Use of the g-csf as adjuvant treatment in connective tissue recontruction - Google Patents

Use of the g-csf as adjuvant treatment in connective tissue recontruction

Info

Publication number
AU2002235991A1
AU2002235991A1 AU2002235991A AU2002235991A AU2002235991A1 AU 2002235991 A1 AU2002235991 A1 AU 2002235991A1 AU 2002235991 A AU2002235991 A AU 2002235991A AU 2002235991 A AU2002235991 A AU 2002235991A AU 2002235991 A1 AU2002235991 A1 AU 2002235991A1
Authority
AU
Australia
Prior art keywords
csf
medicament
treatment
factor
recontruction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002235991A
Inventor
Didier Moukoko
Didier Pourquier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2002235991A1 publication Critical patent/AU2002235991A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

The invention relates to a novel therapeutic application of the G-CSF (Granulocyte Colony-Stimulating Factor). Said factor is used to prepare a medicament that is employed as adjuvant treatment in the reconstruction of connective tissues. The G-CSF is particularly suitable as a medicament in the treatment of bone fractures, osteocartilaginous fractures, pseudo-arthroses, bone fracture consolidation delays, cartilaginous lesions or even ruptured or broken tendons or as a medicament in limb lengthening treatment. The factor is intended to be administered systematically both in human and veterinary medicine.
AU2002235991A 2001-02-22 2002-02-07 Use of the g-csf as adjuvant treatment in connective tissue recontruction Abandoned AU2002235991A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0102406A FR2820979B1 (en) 2001-02-22 2001-02-22 NEW THERAPEUTIC APPLICATION OF G-CSF
FR01/02406 2001-02-22
PCT/FR2002/000480 WO2002066051A1 (en) 2001-02-22 2002-02-07 Use of the g-csf as adjuvant treatment in connective tissue recontruction

Publications (1)

Publication Number Publication Date
AU2002235991A1 true AU2002235991A1 (en) 2002-09-04

Family

ID=8860311

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002235991A Abandoned AU2002235991A1 (en) 2001-02-22 2002-02-07 Use of the g-csf as adjuvant treatment in connective tissue recontruction

Country Status (9)

Country Link
EP (1) EP1365795B1 (en)
AT (1) ATE468133T1 (en)
AU (1) AU2002235991A1 (en)
DE (1) DE60236411D1 (en)
DK (1) DK1365795T3 (en)
ES (1) ES2346044T3 (en)
FR (1) FR2820979B1 (en)
PT (1) PT1365795E (en)
WO (1) WO2002066051A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005032579A1 (en) * 2003-09-02 2005-04-14 Regenetech, Inc. Method of regenerating human tissue
WO2008020638A1 (en) * 2006-08-15 2008-02-21 National University Corporation Kobe University Therapeutic agent for ligament injury

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61227526A (en) 1984-07-25 1986-10-09 Chugai Pharmaceut Co Ltd Novel csf and method of collecting same
US4810643A (en) 1985-08-23 1989-03-07 Kirin- Amgen Inc. Production of pluripotent granulocyte colony-stimulating factor
EP2110431A1 (en) * 1997-05-13 2009-10-21 Osiris Therapeutics, Inc. Cartilage regeneration using human mesenchymal stem cells
EP1028737B1 (en) * 1997-07-03 2007-04-04 Osiris Therapeutics, Inc. Human mesenchymal stem cells from peripheral blood

Also Published As

Publication number Publication date
FR2820979A1 (en) 2002-08-23
WO2002066051A1 (en) 2002-08-29
DK1365795T3 (en) 2010-09-13
ATE468133T1 (en) 2010-06-15
FR2820979B1 (en) 2004-03-12
WO2002066051A8 (en) 2002-11-14
DE60236411D1 (en) 2010-07-01
EP1365795A1 (en) 2003-12-03
PT1365795E (en) 2010-08-19
ES2346044T3 (en) 2010-10-08
EP1365795B1 (en) 2010-05-19

Similar Documents

Publication Publication Date Title
IL144135A0 (en) The preparation and use of radium-223 to target calcified tissues for pain palliation, bone cancer therapy, and bone surface conditioning
IL122196A0 (en) Bicyclic-aromatic compounds
NZ328874A (en) Heterocyclic biaryl compounds and their use in pharmaceutical compositions for treatment of dermatological, rheumatic, respiratory, cardiovascular and ophthalmological disorders
NO20071238L (en) Methods for healing damage by human IL-18 administration
PL323363A1 (en) Biaromatic propynyl or dienyl compounds
MXPA03010628A (en) Vitamin d analogues.
DOWLING et al. Treatment of fractures in burn patients
AU2002235991A1 (en) Use of the g-csf as adjuvant treatment in connective tissue recontruction
Rico et al. Pseudarthrosis of the capitate
NO980375L (en) Human MP52 Arg protein
EP1361905B8 (en) Matrix protein compositions for guided connective tissue growth
Singh Use of MatriDerm®(skin substitute) and split skin graft in one stage in wound healing of exposed tibia without periosteum in two patients
Agarwal et al. Functional Outcome of Plating versus Nailing in Adult Midshaft Radius-Ulna Fractures
Chand et al. Managing difficult fractures due to Ballistic trauma with Ilizarov ring fixation
Khan et al. Results of Minimally Invasive Plate Osteosyntheses in Periarticular Knee Fractures
UA43074A (en) method for treatment of osteoarthrosis
UA43073A (en) method for treatment of osteoarthrosis
Akram et al. Evaluation of results of minimally invasive plating osteosynthesis (MIPO) technique in the treatment of fractures of distal tibia
Kun et al. Treatment of mandibular fracture with combine interdental ligation with minimally invasive expansive compression screws.
AU2003274076A1 (en) Human chondroosteomodulin (tig2), production, and use for the treatment or diagnosis of bone diseases, cartilage diseases, obesity, inflammatory diseases, and skin diseases
HOLGUIN et al. Pseudarthrosis of the Capitate.
Johnson In vitro effects of therapeutic ultrasound on cell proliferation, protein synthesis, and cytokine production by human fibroblasts, osteoblasts, and monocytes
LEWIN RECONSTRUCTIVE TREATMENT OF GUNSHOT WOUND OF FACE AND NECK
Pennig Foreword| Injury-Volume 31, Supplement 1
Peled S333: Treatment of Gunshot Injuries to the Face

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase